Understanding and Preventing Liver Cancer Linked to Metabolic Fatty Liver Disease
Admin Core
This program aims to understand why some people get liver cancer from fatty liver disease and find ways to prevent it.
Quick facts
| Grant type | P01 program project |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11146354 on NIH RePORTER |
What this research studies
This program is dedicated to understanding and preventing a type of liver cancer called hepatocellular carcinoma (HCC), especially when it's linked to metabolic dysfunction-associated fatty liver disease (MAFLD). We are looking into various factors like physical traits, blood markers, and genetic information to identify who might be at higher risk. The goal is to develop better ways to stop this cancer before it starts, including exploring new preventive treatments. This comprehensive effort brings together multiple projects and resources to tackle this serious health challenge.
Who could benefit from this research
Good fit: Patients with metabolic dysfunction-associated fatty liver disease (MAFLD) who are concerned about their risk of liver cancer may find this research relevant.
Not a fit: Patients whose liver cancer is not related to metabolic dysfunction or fatty liver disease may not directly benefit from this specific research focus.
Why it matters
Potential benefit: If successful, this work could lead to earlier identification of individuals at risk for liver cancer and new strategies to prevent its development.
How similar studies have performed: This program builds upon existing knowledge in liver cancer and metabolic disease, aiming to advance understanding and prevention in this specific area.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: El-Serag, Hashem B — Baylor College of Medicine
- Study coordinator: El-Serag, Hashem B
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.